HCC
MHA

Hirtle Callaghan & Co’s MANHATTAN PHARM INC MHA Stock Holding History

Hirtle Callaghan & Co’s Portfolio MHA Stock Details MHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-5,366
Closed -$1K – 691
2013
Q3 		$1K Hold
5,366
– – ﹤0.01% 617
2013
Q2 		$1K Buy
+5,366
New +$1K 0.01% 61

Hirtle Callaghan & Co's MHA Position: Q4 2013 in Review

Hirtle Callaghan & Co sold out of MANHATTAN PHARM INC (MHA) in Q4 2013, closing a stake of 5,366 shares — an estimated $1K sold.

Hirtle Callaghan & Co first reported a position in MHA in Q2 2013 and held it in 2 quarters. The position peaked at $1K in Q3 2013. 0 funds tracked by Wall St. Rank hold MHA as of Q4 2013.

  • Hirtle Callaghan & Co reported no remaining MANHATTAN PHARM INC position as of Q4 2013 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 5,366 MANHATTAN PHARM INC shares in Q4 2013, an estimated $1K.
  • Hirtle Callaghan & Co first reported a position in MANHATTAN PHARM INC in Q2 2013 and held it in 2 quarters.
  • Hirtle Callaghan & Co's MANHATTAN PHARM INC position peaked at $1K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held MANHATTAN PHARM INC as of Q4 2013.

Based on Hirtle Callaghan & Co's 13F filing for Q4 2013, filed 29 Jan 2014.